Current CPRA Calculation Modified on December 5, 2013.

Slides:



Advertisements
Similar presentations
Attaching statistical weight to DNA test results 1.Single source samples 2.Relatives 3.Substructure 4.Error rates 5.Mixtures/allelic drop out 6.Database.
Advertisements

VIRTUAL PRA AND CROSSMATCHING
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Current CPRA Calculation
PRA = 36% (21/58) Anti-A11 and B44.
Acceptable mismatches based on structural epitopes on HLA molecules Toulouse, April 2, 2008.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
. Learning – EM in ABO locus Tutorial #08 © Ydo Wexler & Dan Geiger.
Medical Interventions
One Chance in a Million: An equilibrium Analysis of Bone Marrow Donation Ted Bergstrom, Rod Garratt Damien Sheehan-Connor.
From population genetics to variation among species: Computing the rate of fixations.
Chapter 6 homework Don’t forget homework due Friday… Questions 6, 10, 14, and 16.
The Deceased Donor Kidney Allocation System
OPTN OPTN Kidney Paired Donation Pilot Program Ruthanne L Hanto RN, MPH Program Manager, OPTN KPDPP Regions 4 Meeting May 11, 2012.
Supplementary Table 1 Table S1. Population frequency of HLA -A, -B and -C alleles. Rare alleles (frequency < 0.5%) are highlighted by a grey background.
SOLID PHASE IMMUNOASSAYS: INTERPRETING PATTERNS Julie Houp, CHS Johns Hopkins University School of Medicine Division of Immunogenetics and Transplantation.
Student Demographics Current Native American1.47%1.11%0.96%0.75%0.60% Asian2.53%1.17%1.02%0.99%1.05% Pacific Islander0.41%0.13%0.20%0.26%0.30%
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Hello. ABO BLOOD GROUP SYSTEM Introduction All human blood may look alike but when it is tested using special agents, differences become apparent.
Tissue Typing. E VERYONE HAS SEVERAL ANTIGENS LOCATED ON THE SURFACE OF HIS / HER LEUKOCYTES : One particular group of these antigens is called the HLA.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
Israel David and Michal Moatty-Assa The Search for Compatible Organs – A Handy Aid.
1 Region 10 Meeting Tim Taber, MD Regional Councillor.
PV92 PCR/Informatics Kit Population Genetics and Informatics.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
1 Revising Kidney Paired Donation Pilot Program Priority Points Kidney Transplantation Committee Fall 2015.
1 Proposal to Update the HLA Equivalency Tables Histocompatibility Committee Fall 2015.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
OPTN Minority Affairs Committee Update March 13, 2012 Meeting Chicago O’Hare Hilton.
OPTN/UNOS HISTOCOMPATIBILITY COMMITTEE REPORT TO THE BOARD OF DIRECTORS JUNE 25-26, 2012 RICHMOND, VA Nancy L. Reinsmoen, PhD., Chair.
1 Kidney Transplantation Committee Spring Recent Public Comment Proposals  OPTN Kidney Paired Donation (KPD) Priority Points  Changes apply.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
1 OPTN/UNOS Histocompatibility Committee Fall 2015.
Creating Connections. Saving Lives. ™ NATIONAL MARROW DONOR PROGRAM ® Enhancing Donor Selection: Building Blocks of the New Search Algorithm NMDP Council.
Evan P. Kransdorf, MD, PhD, Michelle M. Kittleson, MD, PhD, Jignesh K
Histocompatibility Committee
Effects of New KPD Histocompatibility Policy on Refusal Rate and Transplants R Leishman1, M Aeder2, M S Leffell3, C Murphey4, N Reinsmoen5, S Saidman6,
Pancreas Transplantation Committee
Hong Kong Workshop Lecture 8 HLA Epitopes and Acceptable Mismatches for Sensitized Transplant Patients.
2015 Kidney Allocation Task Force HLA Working Group
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Histocompatibility Committee
Histocompatibility Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Kidney allocation to highly sensitized patients
Marcelo Pando UNOS Region 5 Collaborative March, 2017
Kidney allocation in the UK
Blood-typing genetics problems
Human Blood Types Exist because there are three proteins that can be found on human red blood cells: A protein B protein Rh Factor [if it’s present, the.
Blood-typing genetics problems
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
RED BLOOD CELLS.
African American.
Biased Gene Conversion Skews Allele Frequencies in Human Populations, Increasing the Disease Burden of Recessive Alleles  Joseph Lachance, Sarah A. Tishkoff 
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Histocompatibility Committee
Kidney Transplantation Committee
Kidney Transplantation Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Haplotypes at ATM Identify Coding-Sequence Variation and Indicate a Region of Extensive Linkage Disequilibrium  Penelope E. Bonnen, Michael D. Story,
Histocompatibility Committee
Histocompatibility Committee
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Histocompatibility Committee
Punnett Square Notes Biology - Ms. Spinale.
Histocompatibility Committee
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Presentation transcript:

Current CPRA Calculation Modified on December 5, 2013

CPRA  Calculated PRA (CPRA) is the percentage of donors expected to have HLA antigens listed as unacceptable for a candidate on the waiting list  CPRA is calculated for kidney, kidney-pancreas and pancreas candidates on the waiting list  If no unacceptable antigens are entered, CPRA value defaults to 0

CPRA (Probability of a positive crossmatch) = 1- (1-Σp i ) 2  CPRA is determined using an established algorithm (1, 2)  It was written by two well-recognized population geneticists and is based upon basic principles of population genetics  Additionally, the entire proposal for CPRA (algorithm, frequencies, etc.) was reviewed by OPTN committees, as well as ASHI, through a panel of three reviewers, that included two population geneticists 1. Zachary AA and Braun WE. Calculation of a predictive value for transplantation. Transplantation 1985;39: Zachary AA and Steinberg AG. Statistical Analysis and Applications of HLA Population Data. In, NR Rose, EC de Marcario, JD Folds, HC Lane, and RM Nakamura, Eds., Manual of Clinical Laboratory Immunology, 5th Edition, Washington, DC, ASM Press, 1997:

Frequencies Current CPRA is calculated based on the data:  HLA frequencies derived from the HLA phenotypes of deceased kidney donors recovered from January 1, 2007 through December 31, 2008  Ethnic frequencies derived from deceased kidney donors recovered from January 1, 2007 through December 31, 2008

CPRA Frequencies  Allele group frequencies were derived by gene counting of the broad and split antigens  Two, three, four, and five locus haplotype frequencies were estimated by the expectation maximization algorithm using Arlequin computer program (3) 3. Leffell MS, Cherikh WS, Land GA, Zachary AA. Improved definition of HLA frequencies among minorities and applicability to estimates of transplant compatibility. Transplantation 2007; 83:

Ethnic Frequencies (Four Major Groups)  CPRA is also based on ethnic frequencies for four major groups (White, African American, Hispanic and Asian ethnicities)  Ethnic frequencies were derived based on deceased kidney donors recovered from January 1, 2007 through December 31, 2008* NumberProportion White 9, African American 2, Hispanic 2, Asian Total14, * Based on OPTN data as of August 19, 2011 Donors of other ancestry comprised about 1% of total number of deceased kidney donors during this period. These groups were not included.

CPRA Calculation 1.Get a list of all unacceptable antigens including equivalences listed in HLA equivalency tables* for all unacceptable antigens (including HLA-C) Example:  A kidney candidate is listed with antibodies to A1, B35, DR11, DQ7 and C7  DQ7 is equivalent to DQ7 and DQ3  A1, B35, DR11 and C7 are only equivalent to themselves  CPRA calculation will use A1, B35, DR11, DQ3, DQ7 and C7 frequencies * The current version of HLA equivalency tables can be found on OPTN site at

CPRA Calculation (cont’d) 2.For each ethnicity separately:  S1 - Sum all the 1 locus haplotype frequencies (A, B, DR, DQ, C)  S2 - Sum all the 2 locus haplotype frequencies (AB, ADR, ADQ, AC, BDR, BDQ, BC, DRDQ, DRC, DQC)  S3 - Sum all the 3 locus haplotype frequencies (ABDR, ABDQ, ABC, ADRDQ, ADRC, ADQC, BDRDQ, BDRC, BDQC, DRDQC)  S4 - Sum all 4 locus haplotype frequencies (ABDRDQ, ABDRC, ABDQC, ADRDQC, BDRDQC)  S5 – Sum all 5 locus haplotype frequencies (ABDRDQC)  CPRA for the ethnicity is: probability of a positive crossmatch = 1 – probability of a negative crossmatch = 1 – (1 – S1 + S2 – S3 + S4 – S5) 2

CPRA Calculation (cont’d)  Since all allele groups weren’t observed within all ethnic groups, some locus haplotypes don’t have frequencies  DR51, DR52, DR53, Bw4 and Bw6 frequencies are based on the approved equivalences listed in HLA equivalency tables

Example* CPRA based on A1, B35, DR11, DQ3, DQ7 and C7 S1 - Sum all the allele (1 locus) frequencies (A, B, DR, DQ, C) White African American HispanicAsian A B DR DQ DQ C Total (S1)

Example (cont’d) CPRA based on A1, B35, DR11, DQ3, DQ7 and C7  S2 - Sum all the 2 locus haplotype frequencies (AB, ADR, ADQ, AC, BDR, BDQ, BC, DRDQ, DRC, DQC) WhiteAfrican AmericanHispanicAsian A1; B A1; DR A1; DQ A1; DQ A1; C B35; DR B35; DQ B35; DQ B35; C DR11; DQ DR11; DQ DR11; C DQ3; C DQ7; C Total (S2)

Example (cont’d) CPRA based on A1, B35, DR11, DQ3, DQ7 and C7 S3 - Sum all the 3 locus haplotype frequencies (ABDR, ABDQ, ABC, ADRDQ, ADRC, ADQC, BDRDQ, BDRC, BDQC, DRDQC) WhiteAfrican AmericanHispanicAsian A1; B35;DR A1; B35; DQ A1; B35; DQ A1; B35; C A1; DR11; DQ A1; DR11; DQ A1; DR11; C A1; DQ3; C A1; DQ7; C B35; DR11; DQ B35; DR11; DQ B35; DR11; C B35; DQ3; C B35; DQ7; C DR11; DQ3; C DR11; DQ7; C Total (S3)

Example (cont’d) CPRA based on A1, B35, DR11, DQ3, DQ7 and C7 S4 - Sum all 4 locus haplotype frequencies (ABDRDQ, ABDRC, ABDQC, ADRDQC, BDRDQC) WhiteAfrican American HispanicAsian A1; B35; DR11; DQ30000 A1; B35; DR11; DQ A1; B35; DR11; C A1; B35; DQ3; C A1; B35; DQ7; C A1; DR11; DQ3; C70000 A1; DR11; DQ7; C B35; DR11; DQ3; C70000 B35; DR11; DQ7; C Total (S4)

Example (cont’d) CPRA based on A1, B35, DR11, DQ3, DQ7 and C7 S5 – Sum all 5 locus haplotype frequencies (ABDRDQC) WhiteAfrican American HispanicAsian A1; B35; DR11; DQ3; C70000 A1; B35; DR11; DQ7; C Total (S4)

Example (cont’d) CPRA based on A1, B35, DR11, DQ3, DQ7 and C7  CPRA for the ethnicity is: 1 - probability of negative crossmatch = 1 – (1 – S1 + S2 – S3 + S4 – S5) 2 WhiteAfrican American HispanicAsian S S S S S Probability of a negative crossmatch Probability of a positive crossmatch

CPRA Calculation 3.Get the final CPRA by applying ethnic weights:  For each ethnicity multiply CPRA for that ethnicity by ethnic weight  Sum all the values to get the final CPRA Example: White African American Hispanic Asian CPRA for ethnicity Ethnic weight CPRA = x x x x = or 83%

See the attached spreadsheet for HLA frequencies used to calculate CPRA